ADVERTISEMENT

Obstructive sleep apnea: noradrenergic+antimuscarinic therapy is safe and effective

Miriam Davis, PhD   |   Clinical Summary   |   15 June 2022
ADVERTISEMENT

Takeaway

  • A meta-analysis finds that pharmacotherapy specifically with combined noradrenergic plus antimuscarinic agents is safe and efficacious for lessening the severity of obstructive sleep apnea (OSA).

Why this matters

  • No pharmacotherapy currently enjoys routine use for OSA.

Study design

  • Systematic review and meta-analysis of 9 randomized controlled trials (RCTs) involving 154...

          

Topic Challenges

left
right